PExA AB (publ)
PExA AB (publ) develops and commercializes diagnostic products in various respiratory diseases. It offers its products for asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary diseases. The company's research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways. It offers PExA 2.0, an instrum… Read more
PExA AB (publ) (FA0) - Total Liabilities
Latest total liabilities as of September 2025: €2.07 Million EUR
Based on the latest financial reports, PExA AB (publ) (FA0) has total liabilities worth €2.07 Million EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
PExA AB (publ) - Total Liabilities Trend (2021–2024)
This chart illustrates how PExA AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
PExA AB (publ) Competitors by Total Liabilities
The table below lists competitors of PExA AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Crypto Co
PINK:CRCW
|
USA | $8.81 Million |
|
Verena Multi Finance Tbk
JK:VRNA
|
Indonesia | Rp2.32 Trillion |
|
AGNICO EAGLE MINES - Dusseldorf Stock Exchang
DU:AE9
|
Germany | €9.31 Billion |
|
ASHDOD REFINERY LTD
TA:ARF
|
Israel | ILA1.07 Billion |
|
SpringBig Holdings Inc.
NASDAQ:SBIG
|
USA | $16.32 Million |
|
Cyanotech Corporation
NASDAQ:CYAN
|
USA | $15.96 Million |
|
Jiankun International Bhd
KLSE:8923
|
Malaysia | RM46.38 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down PExA AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PExA AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PExA AB (publ) (2021–2024)
The table below shows the annual total liabilities of PExA AB (publ) from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €1.96 Million | +2.22% |
| 2023-12-31 | €1.92 Million | -47.06% |
| 2022-12-31 | €3.62 Million | -17.80% |
| 2021-12-31 | €4.40 Million | -- |